Chicago Atlantic BDC Insider Gordon Scott Builds Stake, Signals Confidence as Stock Skims Undervalued Valuation ?

Insider Buying Surge Signals Confidence in a Growing Niche

In the past week, Gordon Scott, the co‑Chief Investment Officer of Chicago Atlantic BDC Inc., added 7,500 shares at a weighted average price of $9.70, raising his stake to 86,608 shares. A follow‑up purchase on August 21 of 195 shares at $9.95 and a later acquisition of 1,520 shares at $10.11 on August 24 bring his cumulative holdings to 88,323 shares. These buys come at a price point that sits just below the current market level of $10.15, indicating that Scott views the stock as undervalued relative to recent trading activity. The fact that he is buying in stages—rather than a single large trade—suggests a disciplined approach aimed at smoothing market impact while maintaining confidence in the company’s trajectory.

What This Means for Investors and the Company’s Outlook

Chicago Atlantic BDC operates as a specialty finance company focused on cannabis and related regulated sectors, a niche that has shown robust growth but also heightened regulatory scrutiny. The recent 5.51% weekly gain and 8.56% monthly rally imply that the market is already pricing in some upside potential, yet the P/E ratio of 7.2 and a market cap of just over $228 million place the stock in a relatively undervalued band for a financial services firm. Insider purchases from a senior executive like Scott can be interpreted as a signal that the management believes the stock’s fundamentals—particularly the company’s ability to secure first‑lien financing and its diversified portfolio across nine industries—will translate into sustained earnings growth. For investors, this insider activity may serve as a catalyst for further demand, potentially nudging the share price upward as the market digests the confidence expressed by those closest to the company’s strategic decisions.

Gordon Scott: A Profile of a Cautious Optimist

Scott’s historical transaction record paints a picture of an insider who actively participates in the company’s capital market while maintaining a disciplined buying rhythm. In the weeks leading up to the August 20 purchase, he executed three buy transactions: 8,200 shares at $9.57, 17,584 shares at $9.54, and 18,300 shares at $9.54, culminating in a post‑trade holding of 79,108 shares. Earlier in 2025, he sold a combined 928,572 shares—likely as part of a liquidity event or tax‑planning exercise—before reinstating a significant stake of 2,887,204 shares in May 2025. His recent purchases are modest in size relative to the total shares outstanding but consistent in timing and price, underscoring a strategy that balances exposure with risk mitigation. The pattern of buying after significant sell-offs also suggests a belief that the stock has entered a more attractive valuation window.

Insider Activity in Context

Other insiders, such as John Mazarakis and Chief Accounting Officer Gianni Lezziere, have also added shares recently, but their volumes are comparatively small. The broader insider activity—highlighting a total of 60,000 shares bought by Mazarakis and 200 shares by Lezziere—indicates a quiet, steady flow of capital from executives. This collective buying pattern, combined with the company’s ongoing shelf registration and its strategy to qualify as a regulated investment company, positions Chicago Atlantic BDC to capitalize on new issuance opportunities while maintaining a stable shareholder base.

Conclusion

Gordon Scott’s incremental purchases, set against a backdrop of a robust weekly rally and a historically low P/E ratio, point to an insider view that the stock is undervalued and poised for continued growth. For investors, the recent insider activity signals management’s confidence in the company’s niche financing strategy and its potential to navigate the regulatory environment of the cannabis sector. While the shares remain relatively inexpensive, the steady accumulation by senior executives may act as a catalyst for further market interest, potentially driving the stock toward its 52‑week high of $11.44.